Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A Nanosensor Toolbox for Rapid, Label-Free Measurement of Airway Surface Liquid and Epithelial Cell Function.

Ivanova R, Benton DCH, Munye MM, Rangseesorranan S, Hart SL, Moss GWJ.

ACS Appl Mater Interfaces. 2019 Mar 6;11(9):8731-8739. doi: 10.1021/acsami.8b14122. Epub 2019 Feb 25.

PMID:
30648848
2.

Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung.

Tagalakis AD, Munye MM, Ivanova R, Chen H, Smith CM, Aldossary AM, Rosa LZ, Moulding D, Barnes JL, Kafetzis KN, Jones SA, Baines DL, Moss GWJ, O'Callaghan C, McAnulty RJ, Hart SL.

Thorax. 2018 Sep;73(9):847-856. doi: 10.1136/thoraxjnl-2017-210670. Epub 2018 May 10.

3.

Nanoscale-targeted patch-clamp recordings of functional presynaptic ion channels.

Novak P, Gorelik J, Vivekananda U, Shevchuk AI, Ermolyuk YS, Bailey RJ, Bushby AJ, Moss GW, Rusakov DA, Klenerman D, Kullmann DM, Volynski KE, Korchev YE.

Neuron. 2013 Sep 18;79(6):1067-77. doi: 10.1016/j.neuron.2013.07.012.

4.

The relationship between functional inhibition and binding for K(Ca)2 channel blockers.

Benton DC, Garbarg M, Moss GW.

PLoS One. 2013 Sep 10;8(9):e73328. doi: 10.1371/journal.pone.0073328. eCollection 2013.

5.

Increased apical Na+ permeability in cystic fibrosis is supported by a quantitative model of epithelial ion transport.

O'Donoghue DL, Dua V, Moss GW, Vergani P.

J Physiol. 2013 Aug 1;591(15):3681-92. doi: 10.1113/jphysiol.2013.253955. Epub 2013 Jun 3.

6.

Method for estimating the tip geometry of scanning ion conductance microscope pipets.

Caldwell M, Del Linz SJ, Smart TG, Moss GW.

Anal Chem. 2012 Nov 6;84(21):8980-4. doi: 10.1021/ac301851n. Epub 2012 Oct 19.

PMID:
23082744
7.

Nanoscale live-cell imaging using hopping probe ion conductance microscopy.

Novak P, Li C, Shevchuk AI, Stepanyan R, Caldwell M, Hughes S, Smart TG, Gorelik J, Ostanin VP, Lab MJ, Moss GW, Frolenkov GI, Klenerman D, Korchev YE.

Nat Methods. 2009 Apr;6(4):279-81. doi: 10.1038/nmeth.1306. Epub 2009 Mar 1. Erratum in: Nat Methods. 2009 Dec;6(12):935.

8.
9.

beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.

Xydas S, Kherani AR, Chang JS, Klotz S, Hay I, Mutrie CJ, Moss GW, Gu A, Schulman AR, Gao D, Hu D, Wu EX, Wei C, Oz MC, Wang J.

J Pharmacol Exp Ther. 2006 May;317(2):553-61. Epub 2006 Jan 18.

PMID:
16421285
10.

A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes.

Bahia PK, Suzuki R, Benton DC, Jowett AJ, Chen MX, Trezise DJ, Dickenson AH, Moss GW.

J Neurosci. 2005 Apr 6;25(14):3489-98.

11.

Macrophage inhibitor, semapimod, reduces tumor necrosis factor-alpha in myocardium in a rat model of ischemic heart failure.

Kherani AR, Moss GW, Zhou H, Gu A, Zhang G, Schulman AR, Fal JM, Sorabella R, Plasse T, Rui L, Homma S, Burkhoff D, Oz MC, Wang J.

J Cardiovasc Pharmacol. 2004 Dec;44(6):665-71.

PMID:
15550785
12.

Magnetic resonance imaging to detect acute cerebral events in on-pump and hybrid-pump patients.

Kherani AR, Lazar RM, Xydas S, Mazzeo PA, Fal JM, Mongero L, Vigilance DW, Morgan JA, Cheema FH, Burton EH, Moss GW, Oz MC.

Heart Surg Forum. 2004 Jun 1;7(4):E265-8.

PMID:
15454375
13.
14.

Measurement of neuropeptide release and dense core granule fusion.

Whim MD, Moss GW.

Methods. 2004 Aug;33(4):265-6. No abstract available.

PMID:
15183173
15.

The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system.

Monaghan AS, Benton DC, Bahia PK, Hosseini R, Shah YA, Haylett DG, Moss GW.

J Biol Chem. 2004 Jan 9;279(2):1003-9. Epub 2003 Oct 14.

16.

Small conductance Ca2+-activated K+ channels formed by the expression of rat SK1 and SK2 genes in HEK 293 cells.

Benton DC, Monaghan AS, Hosseini R, Bahia PK, Haylett DG, Moss GW.

J Physiol. 2003 Nov 15;553(Pt 1):13-9. Epub 2003 Oct 10.

17.

Ion channels in small cells and subcellular structures can be studied with a smart patch-clamp system.

Gorelik J, Gu Y, Spohr HA, Shevchuk AI, Lab MJ, Harding SE, Edwards CR, Whitaker M, Moss GW, Benton DC, Sánchez D, Darszon A, Vodyanoy I, Klenerman D, Korchev YE.

Biophys J. 2002 Dec;83(6):3296-303.

18.

SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones.

Hosseini R, Benton DC, Dunn PM, Jenkinson DH, Moss GW.

J Physiol. 2001 Sep 1;535(Pt 2):323-34.

20.
21.

An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.

Moss GW, Marshall J, Morabito M, Howe JR, Moczydlowski E.

Biochemistry. 1996 Dec 17;35(50):16024-35.

PMID:
8973172
22.
24.

The jellyfish green fluorescent protein: a new tool for studying ion channel expression and function.

Marshall J, Molloy R, Moss GW, Howe JR, Hughes TE.

Neuron. 1995 Feb;14(2):211-5.

25.

Bovine pancreatic trypsin inhibitor as a probe of large conductance Ca(2+)-activated K+ channels at an internal site of interaction.

Moczydlowski E, Moss GW, Lucchesi KJ.

Biochem Pharmacol. 1992 Jan 9;43(1):21-8. Review.

PMID:
1370897
27.

Mapping the polarity profiles of general anesthetic target sites using n-alkane-(alpha, omega)-diols.

Moss GW, Curry S, Franks NP, Lieb WR.

Biochemistry. 1991 Oct 29;30(43):10551-7.

PMID:
1931978
28.
29.
30.

Abortion statutes after Danforth: an examination.

Moss GW.

J Fam Law. 1976;15(3):537-67. No abstract available.

PMID:
11663802
31.

The Second World Conference on Smoking and Health. London, England, September 1971.

Moss GW.

Can J Public Health. 1971 Nov-Dec;62(6):537-41. No abstract available.

PMID:
4399971
32.

Hemoglobin levels and iron intakes of infants attending selected child health centres in the city of Toronto.

Milne H, Beaton GH, Latchford LM, Vaughan M, Moss GW.

Can Med Assoc J. 1971 Aug 7;105(3):279-82.

33.

Brachial and radial artery cutdown.

Moss GW.

Surg Clin North Am. 1969 Dec;49(6):1325-32. No abstract available.

PMID:
5359833
34.

Begg series. 7. Begg management of a gross orthodontic problem.

Moss GW, White RA.

JPO J Pract Orthod. 1969 Mar;3(3):138-49. No abstract available.

PMID:
5253076
35.

Family planning in a co-ordinated hospital and community health setting.

Wilson R, Moss GW, Laugharne EG, Read EM.

Can J Public Health. 1967 Dec;58(12):527-34. No abstract available.

PMID:
5582211
36.

SMOKING AND HEALTH--THE ASSOCIATION AND YOU.

MOSS GW.

Can J Public Health. 1965 Jan;56:34-6. No abstract available.

PMID:
14266383
37.

The epidemiology of infectious hepatitis in Toronto.

MOSS GW.

Can J Public Health. 1962 Mar;53:91-6. No abstract available.

PMID:
14476533
38.

Persistence of antibody following booster dose of poliomyelitis vaccine.

WILSON RJ, MOSS GW, JACOBS JP, MACLEOD DR.

Can J Public Health. 1962 Jan;53:17-21. No abstract available.

PMID:
14007415
39.

An outbreak of Tinea pedis in a public school.

MOSS GW.

Can J Public Health. 1961 Aug;52:324-8. No abstract available.

PMID:
13773128
40.

Observations on the use of antigens.

MOSS GW.

Can J Public Health. 1960 Apr;51:129-34. No abstract available.

PMID:
14424615
41.

[Tetanus and diphtheria anatoxins associated with pertussis and poliomyelitis vaccines. Clinical experience with a quadruple antigen].

WILSON RJ, MOSS GW, POTTER FC MAC LEOD DR.

Minerva Med. 1959 Sep 19;50:2931-4. Italian. No abstract available.

PMID:
13845124
42.

Poliovirus antibody response after various vaccination schedules and at different ages.

MACLEOD DR, ARMSTRONG CW, MOSS GW, POTTER FC, WILSON RJ.

Can Med Assoc J. 1959 Sep 15;81:443-9. No abstract available.

43.

Diphtheria and tetanus toxoids combined with pertussis and poliomyelitis vaccines. Clinical trial of a quadruple antigen.

WILSON RJ, MOSS GW, POTTER FC, MACLEOD DR.

Can Med Assoc J. 1959 Sep 15;81:450-3. No abstract available.

44.

The antibody response to poliomyelitis vaccine in school-children at the time of initial vaccination and one year later.

ARMSTRONG CW, MOSS GW, POTTER FC.

Can J Public Health. 1957 Mar;48(3):96-100. No abstract available.

PMID:
13413743
45.

The efficacy of tetanus toxoid.

MOSS GW, WATERS GG, BROWN MH.

Can J Public Health. 1955 Apr;46(4):142-7. No abstract available.

PMID:
14364376
46.

Immunization: equipment and technique.

MOSS GW, MOSLEY W.

Can J Public Health. 1955 Mar;46(3):128-9. No abstract available.

PMID:
14364374

Supplemental Content

Support Center